[Federal Register Volume 87, Number 241 (Friday, December 16, 2022)]
[Notices]
[Page 77129]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27285]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel HHS-NIH-CDC-SBIR PHS 2020-1 Phase 
II: Antiviral drugs to cure chronic hepatitis B virus infection 
(Topic 84)
    Date: January 18, 2023.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health 5601 Fishers Lane, Room 3F36 
Rockville, MD 20892, (Virtual Meeting).
    Contact Person: Noto K. Dutta, Ph.D., Scientific Review Officer, 
Scientific Review Program Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health 5601 Fishers Lane, Room 3F36, Rockville, MD 
20852, 240-669-2857 [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 12, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-27285 Filed 12-15-22; 8:45 am]
BILLING CODE 4140-01-P